Officer plans to sell ~$969K of Regeneron Pharmaceuticals
Planned, from payLoading…
Insider tradesView the official recordSEC Form 144 — Notice of Proposed Sale of Securities
Planned sale
Director filed to sell about $340K of REGN stock
Planned for Sep 2, 2026 · Notice filed Sep 2, 2026
- ~$340K
- planned to sell · 400 shares, around Sep 2, 2026
Why it stands out
A board member of Regeneron Pharmaceuticals told the SEC they plan to sell $340K of Regeneron Pharmaceuticals shares around Sep 2, 2026. The shares came from their pay, which is the usual reason to sell.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Planned sale date
- Sep 2, 2026
- Reporting period
- Not applicable
- Notice filed with the SEC
- Sep 2, 2026
DirectorPlanned saleShares from pay
Context
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001969223-26-000987
- Filed / recorded
- Sep 2, 2026, 8:09 PM UTC